Come view ABclonal's webinar about our innovative SMab™ technology, the first antibody discovery platform using single primary B cell ex vivo expansion. Dr. Hai Wu outlines the usage of cell sorting, enrichment, bioinformatics, and advanced cloning to avoid the stability issues associated with the traditional hybridoma approach. SMab™ provides valuable flexibility that has generated over 10,000 successful antibody projects and catalog reagents, including against post-translational modifications, small molecules, and can even differentiate between proteins with point mutations.
Please also check out Dr. Beaker's page, which includes information on our BioChat podcast, as well as our blogs where we hope we can inspire you in new research directions!